IVIg protects the 3xTg-AD mouse model of Alzheimer’s disease from memory deficit and Aβ pathology
about
Predicting the Response to Intravenous Immunoglobulins in an Animal Model of Chronic NeuritisRisk Assessment of Neonatal Exposure to Low Frequency Noise Based on Balance in MiceTransgenic autoinhibition of p21-activated kinase exacerbates synaptic impairments and fronto-dependent behavioral deficits in an animal model of Alzheimer's disease.Amyloid β and Tau Alzheimer's disease related pathology is reduced by Toll-like receptor 9 stimulation.A human monoclonal IgG that binds aβ assemblies and diverse amyloids exhibits anti-amyloid activities in vitro and in vivo.IgG Conformer's Binding to Amyloidogenic Aggregates.Amelioration of cognitive impairments in APPswe/PS1dE9 mice is associated with metabolites alteration induced by total salvianolic acid.Effective anti-Alzheimer Aβ therapy involves depletion of specific Aβ oligomer subtypes.A novel recombinant 6Aβ15-THc-C chimeric vaccine (rCV02) mitigates Alzheimer's disease-like pathology, cognitive decline and synaptic loss in aged 3 × Tg-AD mice.Increased Number of Plasma B Cells Producing Autoantibodies Against Aβ42 Protofibrils in Alzheimer's Disease.Should development of Alzheimer's disease-specific intravenous immunoglobulin be considered?Immunotherapies in Alzheimer's disease: Too much, too little, too late or off-target?Novel pathomechanisms in inflammatory neuropathies.Cognitive-Enhancing Effects of a Polyphenols-Rich Extract from Fruits without Changes in Neuropathology in an Animal Model of Alzheimer's Disease.
P2860
Q27320796-993684A5-A018-4AEC-B043-131A6756998EQ30361545-890D873F-B58F-4848-B9DF-0C31F54FD9F8Q33804587-9E054204-2C12-40DF-9F33-EB96D13C7125Q34227162-50016011-6150-4B3D-8663-2A8DDAAE4883Q34473306-24A7CE48-6ABC-4778-94A5-E2D83C42C84FQ35772596-C6CDA672-0943-4CE5-9696-9A51F35B427BQ36328483-85C8A6BB-9C24-4303-B78B-66A8CA3F7959Q36894417-79917F60-D3C4-4F41-8D58-E5B7EB0362EFQ36964826-E4D959B8-A8D4-4963-8FA5-C43197DD6202Q37044228-27F02CF5-0560-4F74-9288-49FC22F243E6Q38283308-941699F2-B479-4519-94DB-03214D601A05Q38675216-41972B70-4E09-4871-8160-F9C02C6C52CFQ47126672-90ED31CD-0CEC-461F-B3AE-2121FDDAFBFEQ50486985-84B55815-59E5-4C7D-B679-79CA8798526F
P2860
IVIg protects the 3xTg-AD mouse model of Alzheimer’s disease from memory deficit and Aβ pathology
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
IVIg protects the 3xTg-AD mous ...... emory deficit and Aβ pathology
@ast
IVIg protects the 3xTg-AD mous ...... emory deficit and Aβ pathology
@en
IVIg protects the 3xTg-AD mous ...... emory deficit and Aβ pathology
@nl
type
label
IVIg protects the 3xTg-AD mous ...... emory deficit and Aβ pathology
@ast
IVIg protects the 3xTg-AD mous ...... emory deficit and Aβ pathology
@en
IVIg protects the 3xTg-AD mous ...... emory deficit and Aβ pathology
@nl
prefLabel
IVIg protects the 3xTg-AD mous ...... emory deficit and Aβ pathology
@ast
IVIg protects the 3xTg-AD mous ...... emory deficit and Aβ pathology
@en
IVIg protects the 3xTg-AD mous ...... emory deficit and Aβ pathology
@nl
P2093
P2860
P3181
P356
P1476
IVIg protects the 3xTg-AD mous ...... emory deficit and Aβ pathology
@en
P2093
Isabelle Paré
Isabelle St-Amour
Katherine Coulombe
Renée Bazin
P2860
P2888
P3181
P356
10.1186/1742-2094-11-54
P577
2014-03-22T00:00:00Z
P5875
P6179
1041583732